Radiation before or after surgery for prostate cancer spread to lymph nodes
Part of Cancer, Kidney & urinary clinical trials.
This Phase 2 trial studies whether giving planned radiation to certain lymph node areas (para-aortic/“PART”) after surgery helps people whose prostate cancer has spread to lymph nodes (pN1). You would be screened after a specific lymph node surgery (ePLND) to see if you match their situation, then receive the trial’s radiation plan and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign consent and be able/willing to follow the treatment and follow-up schedule.
- You have been diagnosed with prostate cancer confirmed by biopsy (tissue testing).
- You have not had any previous treatment for prostate cancer (no prior prostate cancer treatment).
- After a lymph node surgery called ePLND, your results must show pN1 disease as defined by the study protocol.
- You are over 18 years old and able to understand the study information (language/understanding acceptable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at radiation therapy given after prostate surgery (or if needed later) for prostate cancer where lymph nodes were not involved. It may help patients whose PSA rises or who need additional treatment to reduce the chance the cancer comes back.
This Phase 2 study compares two schedules of radiation treatment after prostate surgery in men whose PSA starts rising again. It aims to see which radiation approach works well while tracking quality of life and safety.
This trial compares radical prostatectomy (surgery to remove the prostate) alone versus surgery plus pelvic lymph node removal, with or without additional radiation, for men with intermediate- or high-risk prostate cancer that has not spread. It aims to see which approach is more effective and safe.
This study tests a tailored (personalized) radiation plan for men whose PSA (“prostate blood test”) rises after prostate surgery but who have no detectable spread on scans. It may help control cancer growth by targeting the right area based on your situation.
This trial compares two ways of giving radiation to the prostate and pelvic lymph nodes. It also tests two different instructions for how full your bladder should be during treatment. The goal is to see which approach works better and is easier for patients.
This trial is testing whether a special scan (PSMA PET/CT) before surgery can help doctors decide if you need to remove lymph nodes. It is for men with high-risk prostate cancer who are already planning to have robot-assisted prostate removal.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.